| Effect | Increase |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 4 |
| Gender | Male |
| Age Range | 18-29 |
In young males who suffered from cerebral injuries, 400mg pramiracetam thrice daily was able to improve cognition and memory relative to baseline. No control group for comparison and small sample size.